(1)
Lazzari, G.; Benevento, I.; D’Andrea , B.; Prudente, A.; Brucoli, I.; Bianculli, A.; Tucciariello, R.; Lerose, R.; Metallo, V.; Solazzo, A.; Montagna, A. The Impact of KEYNOTE-522 Related Immune-Related Adverse Events on Concurrent Adjuvant Whole Breast Radiotherapy in the Real World: A Case Series: KEYNOTE-522 and Adjuvant Hypofractionated RT. Arch Breast Cancer 2025, 12, 231-235.